Global Irritable Bowel Syndrome with Constipation drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313378
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbot Laboratories
  • Astellas Pharmaceuticals
  • Nestle
  • Novartis
  • Sucampo Pharmaceuticals
  • Synergy Pharmaceuticals
  • MORE

Higher prevalence of IBS in developed world and prompt address to the need for advanced pharmaceutical measures will facilitate the dominance of Europe IBS-C drugs market on the global front.

IBS is prevalent in general population across the globe for a long period and has affected adversely in terms of medical costs and socioeconomic impact. Increased prevalence of lifestyle related diseases, growth in healthcare spending, augmented patient population suffering from gastrointestinal diseases and medical advancements are the prime contributors to the growth of IBS-C drugs market.

Europe is a combination of varied market trends mutually prevalent across the comprising countries, attributed by the cultural mix and healthcare infrastructures. The region has the largest share in the global IBS-C drugs market and was valued at USD 445.7 Mn in 2015. As IBS patient pool is the highest in the region, the demand for treatment options is also correspondingly high. The prevalence of IBS in European countries ranges from 5% to 25%.

IBS and CI are the two most common gastrointestinal disorders in North America. The conditions together affect more than 30 Million individuals as of 2014. North America also has the highest count of patients suffering from constipation. Evolved healthcare infrastructure, early bird commercialization of IBS-C drugs in the US, better reimbursement policies and higher awareness among both physicians and patient population are the major contributors to the dominance of North America in the global market.

In addition, Asia Pacific is expected to open further avenues for the international players in IBS-C market. APAC is emerging region with the huge scope for the pharmaceutical companies. Japan and China in particular are considered to be very promising countries for drugs market. As Asia is home to half of the world's population, and offers both a large relatively low-cost workforce in some countries and a potentially huge retail market, this region could be central to the future of the global economy.

APAC is the third largest market for the drugs of IBS are many big pharmaceutical companies are investing in for future growth. The number of patients suffering from irritable bowel syndrome accounts to almost 7% of the population. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants and largest number of patients after Japan.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbot Laboratories
  • Astellas Pharmaceuticals
  • Nestle
  • Novartis
  • Sucampo Pharmaceuticals
  • Synergy Pharmaceuticals
  • MORE
Chapter 1 Preface
1.1 Report Scope and Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Global Ibs-C Drugs Market Analysis
3.1 Ibs-C Drugs Market Overview
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Adverse Effects on Health of Various Dietary Habits
3.3.1.2 Strong Clinical Pipeline With Several First-In-Class Molecules
3.3.1.3 Effective Drugs Available in the Market
3.3.2 Restraints
3.3.2.1 Strict Fda Regulations
3.3.2.2 High Level of Ignorance Among the Patients
3.3.3 Opportunities
3.3.3.1 Emerging Apac Market
3.3.3.2 High Unmet Needs
3.4 Attractive Investment Proposition, 2015
3.5 Market Positioning of Key Ibs Drugs Manufacturers

Chapter 4 Global Ibs-C Drugs Market, by Drug Type
4.1 Overview
4.2 Lubiprostone
4.3 Linaclotide
4.4 Stimulant Laxatives
4.4.1 Bisacodyl
4.4.2 Senna
4.5 Osmotic Laxatives
4.5.1 Lactulose
4.5.2 Polyethylene Glycol
4.6 Others (Psyllium) - Qualitative Information
4.7 Pipeline Drug Analysis: Plecanatide (Year of Launch to 2022 ($ Million))

Chapter 5 Global Ibs-C Drugs Market by Prescription Type
5.1 Overview
5.2 Prescribed Drugs
5.3 Over the Counter Drugs

Chapter 6 Global Oic Drugs Market, by Geography
6.1 Global Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of the Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific (Apac)
6.5 Rest of the World (Row)
6.5.1 Middle East and Africa
6.5.2 Latin America
6.5.3 Rest of the Row

Chapter 7 Company Profiles
7.1 Catalent Pharmaceuticals Solutions
7.1.1 Overview
7.1.2 Catalent Pharma Solutions Product Portfolio
7.1.3 Scot Analysis
7.2 Nestle
7.2.1 Overview
7.2.2 Nestle Products Portfolio
7.2.3 Scot Analysis
7.3 Abbot Laboratories
7.3.1 Overview
7.3.2 Abbott Laboratory Product Portfolio
7.3.3 Scot Analysis
7.4 Synergy Pharmaceuticals
7.4.1 Overview
7.4.2 Synergy Pharmaceuticals Products Portfolio
7.4.3 Scot Analysis
7.5 Sucampo Pharmaceuticals
7.5.1 Overview
7.5.2 Sucampo Pharmaceuticals Product Portfolio
7.5.3 Scot Analysis
7.6 Novartis
7.6.1 Overview
7.6.2 Novartis Products Portfolio
7.6.3 Scot Analysis
7.7 Astellas Pharmaceuticals
7.7.1 Overview
7.7.2 Astellas Pharmaceuticals Product Portfolio
7.7.3 Scot Analysis

List of Figures
Figure 1 Global Ibs-C Drugs Market 2014-2022 (USD Mn)
Figure 2 Global Ibs-C Drugs Market, by Prescription Type, 2014 (%)
Figure 3 Ibs-C Prevalence Statistics, 2014 (%)
Figure 4 Diets Responsible for Ibs
Figure 5 Percentage of Persons Aged 12 and Over With Depression by Age and Sex, Us, 2009-2012
Figure 6 Drugs for Irritable Bowel Syndrome Constipation
Figure 7 Lifestyle and Home Remedies for Ibs
Figure 8 Drugs Pulled Off from the Market
Figure 9 Ibs Professional Reference Statistics
Figure 10 Population of Asia by Age Group in Various Sub Region, July 2013
Figure 11 Global Lubiprostone Market, by Region, 2014-2022 (USD Mn)
Figure 12 Pipeline Drug Analysis: Plecanatide (Year of Launch to 2022 (US$ Mn))
Figure 13 U.S. Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 14 U.S. Prescribed Ibs-C Drugs Market, by Prescription Type, 2014-2022 (USD Mn)
Figure 15 Canada Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 16 U.K. Ibs-C Drugs Market, 2014-2022 (%)
Figure 17 Germany Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 18 Rest of Europe Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 19 Asia Pacific Oic Drugs Market, by Country, 2014-2022 (USD Mn)
Figure 20 China Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 21 Japan Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 22 Apac Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 23 Row Ibs-C Drugs Market, by Region, 2014-2022 (USD Mn)
Figure 24 Middle East and Africa Oic Drugs Market, 2014-2022 (USD Mn)
Figure 25 Latin America Ibs-C Drugs Market, 2014-2022 (USD Mn)
Figure 26 Rest of Row Ibs-C Drugs Market, 2014-2022 (USD Mn)

List of Tables
Table 1 Global Ibs-C Drug Market by Geography 2014-2022 (USD Mn)
Table 2 Prominent Ibs Treatment Drugs
Table 3 Ibs Drugs List
Table 4 Global Oic Drug Market by Drug Type, 2014-2022 (USD Mn)
Table 5 Product Profile (Lubiprostone)
Table 6 Linaclotide Market by Region, 2014-2022 (USD Mn)
Table 7 Product Profile: Linaclotide
Table 8 Global Stimulant Laxatives Market by Region, 2014-2022 (USD Mn)
Table 9 Ibs Bisacodyl Market by Region, 2014-2022 (USD Mn)
Table 10 Product Profile: Bisacodyl
Table 11 Ibs Senna Market by Region, 2014-2022 USD Mn)
Table 12 Ibs Senna Market by Region, 2014-2022 USD Mn)
Table 13 Global Lactulose Market by Region, 2014-2022 (USD Mn)
Table 14 Product Profile: Lactulose
Table 15 Global Polyethylene Glycol Market by Region, 2014-2022 (USD Mn)
Table 16 Product Profile: Polyethylene Glycol
Table 17 Ibs Professional Reference Statistics
Table 18 Product Profile: Plecanatide
Table 19 Global Prescribed Ibs-C Drugs Market, by Prescription Type, 2014-2022 (USD Mn)
Table 20 Global Prescribed Branded Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
Table 21 Global Prescribed Generic Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
Table 22 Global Over the Counter Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
Table 23 Global Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
Table 24 Global Ibs-C Drugs Market, by Geography, 2014-2022 (USD Mn)
Table 25 Us Ibs-C Drugs Market, by Drug Type, 2014-2022 (USD Mn)
Table 26 Europe Ibs-C Drugs Market, by Country, 2014-2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Catalent Pharmaceuticals Solutions
  • Nestle
  • Abbot Laboratories
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Novartis
  • Astellas Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll